Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis-Reference-Cited by-同舟云学术

Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis

Published:2023-01 Issue: Volume:9 Page:100115
ISSN:2666-9706
Container-title:Diabetes Epidemiology and Management
language:en
Short-container-title:Diabetes Epidemiology and Management

Author:

Chou Oscar Hou In^ORCID,Zhou Jiandong,V Mui Jonathan,Satti Danish Iltaf,Chung Cheuk To,Tai Loy Lee Teddy,Lee Sharen,Dee Edward Christopher,Ng Kenrick,Cheung Bernard Man Yung,Jing Fengshi,Tse Gary

Publisher

Elsevier BV

Subject

General Medicine

Reference50 articles.

1. Burden of Pancreatic Cancer: From Epidemiology to Practice;Khalaf;Clin Gastroenterol Hepatol,2021

2. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors;Rawla;World J Oncol,2019

3. Pancreatic cancer: an increasing global public health concern;Cabasag;Gut,2021

4. Acute Pancreatitis;Gapp,2022

5. Acute Pancreatitis: Etiology, Pathology, Diagnosis, and Treatment;Majidi;South Med J,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-05-27

2. Diagnostic Differentiation between Pancreatitis and Pancreatic Cancer: A Scoping Review;Diagnostics;2024-01-29

3. Nasopharyngeal Carcinoma and Head and Neck Cancer in Patients with Type-2 Diabetes Mellitus receiving SGLT2I, DPP4I or GLP1a: A population-based cohort study;2024-01-15

4. New-onset prostate cancer in type 2 diabetes mellitus exposed to the SGLT2I, DPP4I and GLP1a: A population-based cohort study;2023-11-27

5. Compare SGLT2I versus non-SGLT2I users in type-2 diabetic mellitus patients on GLP-1 receptor agonist: A population-based and machine learning causal inference analysis;2023-11-07